Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
60,902
-
Share change
-
+1,729
-
Total reported value
-
$158,954
-
Price per share
-
$2.61
-
Number of holders
-
2
-
Value change
-
+$4,513
-
Number of buys
-
1
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2023
As of 31 Dec 2023,
Summit Therapeutics Inc. - COM (SMMT) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,902 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, MORGAN STANLEY, Steward Partners Investment Advisory, LLC, Nuveen Asset Management, LLC, and ALPS ADVISORS INC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.